|
|
Antidoping Svizzera. (2010). Doping? : niente scuse! Tu sei responsabile delle tue azioni. Berna: Author.
Abstract: Questo opuscolo si rivolge a giovani sportive e sportivi che desiderano informarsi sulle regole e sui controlli antidoping. È rivolto anche al personale di supporto e a coloro che s’interessano di sport. Qui troverai tutte le informazioni essenziali sul doping, sui controlli antidoping e sull’uso di medicamenti e integratori alimentari.
Keywords: prevention; amateur and professional sports; doping; specific AODU measurement and test; addiction; AOD dependence; chemical addiction
|
|
|
|
European Monitoring Centre for Drugs and Drug Addiction, & Europol. (2010). Cocaine : a European Union perspective in the global context. Luxembourg: Publications Office of the European Union.
Abstract: This report provides an overview of what is known about how cocaine is produced and trafficked into the European Union. It aims to provide a better understanding of the actors involved, the routes taken, and the scale of the problem in Europe. It also reviews some of the supply reduction responses already developed at European level. Its findings are based on the latest data and analysis available from specialised European and international organisations, NGOs and scholars. This publication is structured in a way that provides a condensed review of key issues relevant to understanding how cocaine reaches European markets. Background information on the chemistry and legal status of cocaine and crack cocaine, as well as key European figures, are also provided.
Keywords: addiction; AOD dependence; chemical addiction; cocaine; crack cocaine; illegal production of drugs; drug trafficking; drug market; international area; Europe
|
|
|
|
Highleyman, L. (2010). HCV NS5A inhibitor BMS-790052 suppresses viral replication in combination with pegylated interferon/ribavirin (HIV and Hepatitis.com, Ed.). San Francisco: HIV and Hepatitis Treatment Advocates.
Abstract: SUMMARY: BMS-790052, Bristol-Myers Squibb’s investigational hepatitis C virus (HCV) NS5A inhibitor, demonstrated potent early antiviral activity at 4 and 12 weeks when combined with the standard regimen of pegylated interferon plus ribavirin in previously untreated patients with HCV genotype 1, investigators reported at the at the 45th Annual Meeting of the European Association for the Study of the Liver (EASL 2010) this month in Vienna.
Keywords: health promotion; viral hepatitis; hepatitis C; drug therapy; patient; conference
|
|
|
|
saferparty.ch (Ed.). (2010). Research Chemicals. Zürich: Streetwork Zürich.
Abstract: Aufgrund der Zunahme von Medienberichten zur Research Chemicals (RC) haben wir uns entschieden die aktuellsten Infos zu den häufigsten RC’s zusammenzutragen. Bezüglich der Konsumsituation ist es uns wichtig festzuhalten, dass der Konsum von Research Chemicals im Raum Zürich eine Seltenheit darstellt. RC’s werden nur von einem kleinen Teil der “Partydrogenkonsumenten” konsumiert. Bis zum jetzigen Zeitpunkt werden unseres Wissens RC’s auch noch nicht an Partys oder auf dem Schwarzmarkt gehandelt, sondern ausschliesslich über das Internet bestellt. In sehr seltenen Fällen werden RC’s, vor allem Mephedrone, auch als XTC Tabletten verkauft. Wie sich der Konsum von RC’s in Zukunft entwickelt, ist schwierig vorauszusagen, wir werden diesen aber weiterhin im Auge behalten und sie gegebenenfalls über aktuelle Tendenzen informieren!
Keywords: addiction; chemical addiction; AOD dependence; designer drug; research chemical; mephedrone; amphetamines; piperazine; harm reduction; prevention; fact sheet
|
|
|
|
Addiction Info Suisse (Ed.). (2010). L'alcool durant la grossesse : informations pour les femmes enceintes, leur partenaire et leur entourage. Lausanne: Addiction Info Suisse.
Keywords: alcohol; target group; woman; pregnancy
|
|
|
|
Menzi, P., Bernhardt Keller, A., Monterrubio Leu, C., & Galgano, M. L. (2010). Hepatitis C : prevention and treatment : a summary of key facts. Berne: Infodrog.
Keywords: health promotion; viral hepatitis; hepatitis C
|
|
|
|
lycaeum.org (Ed.). (1999). Ayahuasca FAQ. Lycaeum.
Keywords: addiction; AOD dependence; chemical addiction; other AOD substances
|
|
|
|
lycaeum.org (Ed.). (1997). Ayahuasca FAQ : contents. Lycaeum.
Keywords: addiction; AOD dependence; chemical addiction; other AOD substances
|
|
|
|
Division Produits chimiques, & Centre suisse d'information toxicologique. (2009). Gamma-hydroxybutyrate (GHB), gamma-butyrolactone (GBL), 1,4-butanediol (BD) : fiche d'information. Berne; Zurich: Office fédéral de la santé publique (OFSP), Division Produits chimiques; Centre suisse d'information toxicologique (CSIT).
Keywords: addiction; chemical addiction; AOD dependence; other AOD substances; gamma-butyrolactone; gamma-hydroxybutyric acid; history; risk; epidemiology; AOD intoxication; first aid; treatment and maintenance; law; drug laws
|
|
|
|
Sezione prodotti chimici, & Centro svizzero d'informazione tossicologica. (2009). Gamma-idrossibutirrato (GHB), gamma-butirrolattone (GBL), 1,4-butandiolo (BD) : scheda informativa. Berna; Zurigo: Ufficio federale della sanità pubblica (UFSP), Sezione prodotti chimici; Centro svizzero d'informazione tossicologica (CSIT).
Keywords: addiction; chemical addiction; AOD dependence; other AOD substances; gamma-butyrolactone; gamma-hydroxybutyric acid; history; risk; epidemiology; AOD intoxication; first aid; treatment and maintenance; law; drug laws
|
|
